PriMedShines will be exhibiting at the (Association for Research in Vision & Ophthalmology Annual Meeting) ARVO 2019 in Vancouver, BC. on the 28 April- 2 May 2019. Please drop by and find out more about Primed and the services that we offer in spontaneous NHP Ophthalmology disease models. Lookforward to welcome you at Booth #1441 at the Vancouver Convention Centre.ARVO hosts the largest meeting of

This end of September, vision scientists and researchers from Harvard Medical SchoolHarvard Ophthalmology/Mass. Eye and Ear MEEI came together to discuss the latest topics in eye research, ranging from novel biomarkers and vascular pathogenesis to inflammation. The goal of this workshop is to accelerate innovative eye research using NHP research and hopefully to eradicate blinding diseases.

April 29 - May 3，2018, at the Annual meeting of association for research in vision and ophthalmology (ARVO), Primed presented the latest NHP ophthalmic research capabilities. Primed’s exhibiting booth (1704) became the focus...

April 18, 2018Primed Shines Co., Ltd, a leading science-driven, technologically advanced, high-quality preclinical research partner, will showcase their scientific expertise of ocular disease in nonhuman primates at this year’s meeting of...

“The history of cancer research has been a history of curing cancer in the mouse. We have cured mice of cancer for decades—and it simply didn’t work in humans.” This statement was made by Richard Klausner, M.D., former director of the...

On March 2018, Baowen Li joined Primed Team as the Chief Coperation Officer and Vice President to help push for further growth. Prior to join in PriMed, Prof. Li was Deputy Director of Laboratory Animal Resource Institute...

On March 5, 2018, PriMed Bio-tech Group Co., Ltd, a leading science-driven, technologically advanced, high-quality preclinical research partner, received the 3-year on-site review from the Association for the Assessment and Accreditation of...

In January, Professor Dongfeng Chen from Harvard Medical School was appointed as our senior consultant in ophthalmic disease research.Dr. Dong Feng Chen is associate scientist of Schepens Eye Research Institute and associate professor of...

PriMed Bio-tech Group Co., Ltd, visited Harvard Mass. Eye and Ear., a leading science-driven, technologically advanced,high-quality preclinical research discussion, discussed the related ophthalmology...

2017 (3rd) International Symposium on Innovative Medicine Research & Development and Translational Strategy was successfully held by Sichuan PriMed Bio-tech Group Co., Ltd., and Chengdu PriMed HuaYing Bio-tech Co., Ltd. in Chengdu on Sep. 25th...